Day: May 13, 2022

Condor Gold Plc (“Condor Gold”, “Condor” or the “Company”) LONDON, May 13, 2022 (GLOBE NEWSWIRE) — Condor Gold (AIM: CNR; TSX: COG) announces that it has today published its unaudited financial results for the three months ending 31 March 2022 and the Management’s Discussion and Analysis for the same period. Both of the above have been posted on the Company’s website www.condorgold.com and are also available on SEDAR at www.sedar.com. Highlights for the First Quarter of 2022:On March 10, 2022, the Company announced that all assay results have been received for an 8,004 m infill drilling programme on the fully permitted high-grade La Mestiza Open Pit Mineral Resource at La India Project. Advanced the technical studies needed for the completion of a Definitive Feasibility Study covering the La India open pit, the processing plant...

$532.2 Million in Total Cash at Quarter End; Strong Balance Sheet Expected to Support Operations into Second Half of 2024 Additional Data from Adintrevimab Phase 2/3 STAMP Treatment Trial to be Presented at ASM Annual Meeting WALTHAM, Mass., May 13, 2022 (GLOBE NEWSWIRE) — Adagio Therapeutics, Inc. (Nasdaq: ADGI), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases, today reported financial results for the quarter ended March 31, 2022. “We continue to be encouraged by adintrevimab’s potential as a prophylactic and treatment option for certain variants of SARS-CoV-2, which is supported by the positive data that met all primary endpoints from our global EVADE and STAMP trials. We continue to engage with the FDA and are closely monitoring...

PARSIPPANY, N.J., May 13, 2022 (GLOBE NEWSWIRE) — Embecta Corp. (“embecta”) (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world following its April 1, 2022, spin off from Becton, Dickinson and Company (“BD”), today reported financial results for the three- and six-month periods which ended March 31, 2022, and provided financial guidance for the last six months of the fiscal year ending September 30, 2022. “Our global team successfully executed the spin off from BD while meeting our commitments and maintaining the high level of service that our customers and the millions of people with diabetes that use our products deserve and expect,” said Devdatt “Dev” Kurdikar, Chief Executive Officer of embecta. “Listing the independent company’s stock on Nasdaq on April 1 was an inspiring and unifying...

Maintains Full Year 2022 OutlookContinues to Forecast Growth for the Remainder of the Fiscal YearPlans for Pricing Execution, Innovation, and New Retail Distribution Remain on Track LOS ANGELES, May 13, 2022 (GLOBE NEWSWIRE) — The Honest Company (NASDAQ: HNST), a digitally native, mission-driven brand focused on leading the clean lifestyle movement, today reported financial results for the three months ended March 31, 2022. “In the face of significant macro headwinds, I’m pleased we are able to maintain our financial outlook for the year. Consistent with the expectations we communicated on our last earnings call, the first quarter of 2022 experienced challenging comparisons year-over-year as well as softness in the digital space as many consumers returned to in-store shopping in our product categories. With the first quarter behind...

BUILDING A SOLID BASE OF VAZALORE® USERSTotal Net Sales of $2.1 Million in the First Quarter of 2022, an Increase of Approximately 31% from Fourth Quarter of 2021 GAAP Net Loss of ($0.39) Per Diluted Share in the First Quarter 2022; Adjusted Non-GAAP Net Loss Per Diluted Share of ($0.66) Cash & Cash Equivalent Balance of $52.5 Million as of March 31, 2022 Disciplined Spending to Support Strategic GrowthSPARTA, N.J., May 13, 2022 (GLOBE NEWSWIRE) — PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), is a commercial-stage drug delivery platform technology company focused on its clinically-validated and patent-protected PLxGuard™ that has the potential to improve the absorption of many drugs currently on the market and to reduce the risk of stomach injury associated with certain drugs. The Company, with its lead products...

MIAMI BEACH, Fla., May 13, 2022 (GLOBE NEWSWIRE) — AirSculpt Technologies, Inc. (NASDAQ:AIRS)(“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today announced results for the first quarter ended March 31, 2022.Cases increased 31.1% from prior year period to 3,156 cases Revenue increased 51.3% from prior year period to $39.5 millionSame-center cases increased 12.2% from the prior year period Same-center revenue per case increased 14.6% from the prior year periodNet loss was $(0.7) million Adjusted EBITDA increased to $9.8 million Cash flow from operations was $7.1 million“Once again, we were able to produce outstanding year over year revenue growth of over 51%. The first quarter was the highest volume and revenue in the history of our company and demand for AirSculpt has never been...

HONOLULU, May 13, 2022 (GLOBE NEWSWIRE) — Barnwell Industries, Inc. (NYSE American: BRN) today reported net earnings of $2,052,000, $0.21 per share, and $3,125,000, $0.33 per share, for the three and six months ended March 31, 2022, respectively, as compared to net losses of $856,000, $0.10 per share, and $272,000, $0.03 per share, for the three and six months ended March 31, 2021, respectively. Mr. Alexander C. Kinzler, Chief Executive Officer of Barnwell, commented, “We are pleased to report that our quarterly oil and natural gas revenues more than doubled as well as a significant increase in land segment revenues, which contributed to our increase in earnings as compared to last year’s three months ended March 31, 2021. “Our oil and natural gas operating margins improved as prices increased for all products; oil, natural gas,...

THORNTON, CO, May 13, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Ascent Solar Technologies, Inc. (“Ascent Solar” or the “Company”) (OTCMKTS: ASTI), a developer and manufacturer of state-of-the-art, lightweight, flexible thin-film photovoltaic (PV) solutions, reported results for the quarter ended March 31, 2022. First Quarter 2022 Financial Summary:Net revenue for the first quarter 2022 was $566k, an increase of $401k, or 243%, from the corresponding quarter in 2021. Net revenue included non-recurring engineering fees of $512k. Costs and expenses increased 102% to $2.8M in the first quarter of 2022 compared to $1.4M in the corresponding quarter last year, when the company was continuing to re-emerge from its dormant period. The Company continues to add headcount and expand operations, and saw a first quarter 2022 loss from...